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cara canis,  and  coccidia  of  the  genus  Isospora. 
Even though serious complications are not com-













zuril  acts  as  a  coccidiocide.  The  efficacy  of  the 
suspension  against  nematodes  (Toxocara canis, 
Ancylostoma caninum, Uncinaria stenocephala) 
and Isospora spp. (I. canis, I. ohioensis-complex: 




























prepatent  Isospora  spp.  infection. The different 
study designs are summarised in Tab. 1.
In  studies no.  1 and 2 dogs  that had been posi-




















































































































































Study 1 Study 2 Study 3 Study 1 Study 2 Study 3 Total




31 14 40 41 26 102 169










































In  study  no.  2  the  dogs  in  the  control  group 
received powder containing sulfadimethoxine for 
oral application with food or water (Kokzidiol SD®, 











Studies no. 1 and 2:








In  study  no.  1  post  treatment  geometric mean 



































quently  observed  nematode  species  while  the 



































T. canis, A. caninum 1 0.5
T. canis, U. stenocephala 3 1.5
T. canis, T. vulpis 3 1.5
T. canis, U. stenocephala, T. vulpis 1 0.5
T. leonina, T. vulpis 1 0.5




T. canis, I. ohioensis-complex 22 11.2
U. stenocephala, I. ohioensis-complex 1 0.5
T. canis, I. canis, I. ohioensis­complex 1 0.5
I. canis, T. vulpis 1 0.5
Isospora spp. 2.5 % I. canis, I. ohioensis-complex 5 2.5






I. ohioensis-complex, T. canis 10 4.9
I. ohioensis-complex, I. canis, T. canis 7 3.4
Isospora spp. 2.9 % I. canis, I. ohioensis-complex 6 2.9













nematode  and  Isospora  spp.  infections  in  dogs 
under field conditions. In addition to the treatment 
of patent infections, also the efficacy of a treatment 


























Geometric mean FEC (EPG)
Reduction










Geometric mean FOC (OPG) FOC reduction
Pre tr. Day 3 Day 7
Day  
9 ± 1
Post tr.  
day 7/9 ± 1
(95 % CI)
Day 3 Day 7 Day 9 ± 1
Post tr.




2,852 3 0.5 0.6 1 (0.01 – 3.4) 99.9 % 100.0 % 100.0 % 100.0 %
Sulfadimethoxine 
powder











































during  the  year  despite  quarterly  anthelmintic 
treatment. Only  few  publications  evaluate  gas-
trointestinal  parasite  prevalence  in  unweaned 

























Geometric mean FOC (OPG)
Range of FOC 




Post treatment period =




0 1.7 (0.06 – 5.9) 0 – 3,750  98.7 %





























































dence  of Neospora caninum  and  other  intestinal  proto-
zoan parasites in populations of Swiss dogs. Vet Parasitol 
139:84 – 92. 
Schimmel A, Schroeder I, Altreuther G, Settje T, Charles S, 
Wolken S, Kok DJ, Ketzis J, Young D, Hutchens D, Krieger 
KJ (2011) Efficacy of emodepside plus toltrazuril (Procox® 
oral suspension for dogs) against Toxocara canis, Uncinaria 
stenocephala and Ancylostoma caninum in dogs. Parasitol 
Res 109:1 – 8.
Seeliger U (1999) Feldstudie zur Epidemiologie und Bekämp-
fung der Isosporose des Hundes. Dissertation, Tierärztliche 
Hochschule Hannover.
VICH guideline 7: Efficacy requirements for anthelmintics: 
overall  guidelines. Veterinary  International Cooperation 
on Harmonization, European Agency for the Evaluation of 
Medicinal Products, London, December 2000.
VICH guideline 9: Good clinical practice. Veterinary Inter-
national Cooperation on Harmonization, European Agency 
for the Evaluation of Medicinal Products, London, July 2000.
VICH guideline 19: Efficacy of anthelmintics: specific recom-
mendations for canine. Veterinary International Coopera-
tion on Harmonization, European Agency for the Evaluation 
of Medicinal Products, London, July 2001.
